Also, expanding regulatory approvals for obesity indications have reinforced this segments dominance
An open discussion with your provider about your full health history will help ensure that a compounded GLP-1 medication, if prescribed, is appropriate for your individual situation
In April 2026, NICE recommended semaglutide, alongside a reduced-calorie diet and increased physical activity, to lower the risk of heart attack, stroke or dying of heart disease in people with a BMI (body mass index) of 27 or above who have one of the following: heart attack stroke (caused by a blood clot or bleeding) symptomatic peripheral arterial disease (PAD), such as intermittent claudication with a BPI (brachial pressure index) score of less than 0.85, previous interventions to improve blood flow, or an amputation due to PAD
Avoid high-fat, greasy, fried, and very sweet foods during the adjustment period
2004 Jul.